GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Brooks Laboratories Ltd

Brooks Laboratories Sells Shares in Brooks Steriscience for Rs. 106.33 Crore

BOARD ▲ Positive Development LOW RISK
📅 Filed on BSE: 19 Jun 2026, 09:32 PM IST  ·  BSE ID: bc1040ab-c31f-4952-8799-4a063ed1b221
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board approved selling a portion of its stake in a subsidiary for about Rs. 106 crore.
🤖 AI Summary
  • Brooks Laboratories approved sale of 51,220 equity shares in Brooks Steriscience for ~Rs. 106.33 crore.
  • Sale is to Steriscience Specialties Private Limited at Rs. 20,760 per share.
  • Transaction represents partial divestment, not a complete exit from subsidiary.
  • Company will continue to hold 1,02,440 shares, representing 32.67% stake.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Number of Equity Shares Sold
51,220
Sale Price Per Share
₹20,760
Total Cash Consideration
₹106.33 crore
Percentage Stake Retained
32.67%
🏢 How This Affects the Company
📈
Business Impact
This transaction involves a partial divestment of investment in a subsidiary, impacting the structure of the company's holdings.
💰
Financial Impact
The sale will result in a cash inflow of approximately Rs. 106.33 crore, enhancing the company's liquidity.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders are indirectly affected by the company's decision to monetize an investment and retain a stake.
🔍
Management Signal
Management is actively managing its investment portfolio to generate cash while maintaining strategic interests.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Completion of customary documentation for share sale.
Future financial reports detailing cash inflow impact.
Announcements regarding the ongoing strategic involvement in Brooks Steriscience.
LOW RISK Standard transaction with clear terms and a retained stake.
💡 Investor Takeaway
Brooks Laboratories will sell 51,220 shares in Brooks Steriscience for ~Rs. 106.33 crore at Rs. 20,760 per share, retaining a 32.67% stake.
⚖️ Strengths & Concerns

✅ Positives

  • Partial monetization of investment in Brooks Steriscience generates approximately Rs. 106.33 crore cash.
  • Company retains a significant 32.67% stake in Brooks Steriscience post-transaction.
❓ Frequently Asked Questions
What did Brooks Laboratories' Board approve on June 19, 2026?
The Board approved the sale of 51,220 equity shares held in Brooks Steriscience Limited for a cash consideration of approximately Rs. 106.33 crore.
What is the sale price per share for Brooks Steriscience shares?
The sale price is Rs. 20,760 per equity share.
Who is buying the shares from Brooks Laboratories?
Steriscience Specialties Private Limited is acquiring the shares.
Will Brooks Laboratories exit its investment in Brooks Steriscience?
No, this is a partial divestment. Brooks Laboratories will continue to hold 1,02,440 Equity Shares, representing 32.67% of the paid-up share capital.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.